CD8A and neoplasm: In contrast, IL-12 acts as a key regulator of the immune response against tumors, promoting M1 macrophage polarization, the Th1 lymphocytes response, the activation of CD8+ T cells and NK cells, along with other mechanisms inhibiting tumor growth and progression [11,26,65].